UPG-108
UPG-108, a peptide compound, is a non-competitive allosteric modulator of Urotensin II receptors (UTR). UPG-108 significantly enhances the efficacy of UTR agonists but reduces the potency of UTR agonists. UPG-111 efficiently induces calcium release and does not cause contraction of rat aortic rings without endothelial denudation. UPG-111 can be used to study various diseases related to the angiotensinergic system.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3090686-88-4
- 화학식: C65H88N14O17S2
- 분자량:1401.61
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 3090686-88-4
-
분자량 1401.61
-
화학식 C65H88N14O17S2
-
Sequence
Glu-Thr-Pro-Glu-Asp-{Pen}-Phe-{d-Trp}-{Orn}-Tyr-Cys-Val (Disulfide bridge: Pen-Cys)
-
Sequence Shortening
ETPED-{Pen}-F-{d-Trp}-{Orn}-YCV (Disulfide bridge: Pen-Cys)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- UPG-108
- 3090686-88-4
- UPG108
- UPG 108
- Urotensin Receptor
- Urotensin II receptor (UTR)
- Super-agonist
- Positive allosteric modulator (PAM)
- Lateral allostery
- GPCR multimer
- Structure-activity relationship (SAR)
- N-terminal peptide engineering
- Noncompetitive modulation
- Calcium mobilization
- Rat aorta contraction
- Inhibitor
- inhibitor
- inhibit